GLP-3 is a next-generation investigational peptide being studied for its unique triple-agonist activity targeting the GLP-1, GIP, and glucagon receptors. In preclinical and laboratory research models, compounds with this mechanism have demonstrated significant effects on metabolic signaling pathways associated with energy expenditure, glucose regulation, and adipose tissue metabolism. Due to its multi-receptor activity, GLP-3 has generated substantial interest within the scientific community as a tool for exploring advanced metabolic modulation and weight-regulation pathways.

This compound is intended strictly for laboratory and research purposes only.